CELZ

Creative Medical Technology Holdings, Inc. Common Stock

1.87

USD

CELZ Earnings Reports

Positive Surprise Ratio

CELZ beat 7 of 16 last estimates.

44%

Next Report

Date of Next Report

May 07, 2026

Estimate for Q1 26 (Revenue/ EPS)

Implied change from Q4 25 (Revenue/ EPS)

Implied change from Q1 25 (Revenue/ EPS)

Creative Medical Technology Holdings, Inc. Common Stock earnings per share and revenue

On Mar 12, 2026, CELZ reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.37 USD, resulting in a --% surprise. Revenue reached 3.00 thousand, compared to an expected --, with a 0.00% difference. The market reacted with a -3.09% price change (close before vs. close after earnings).

Looking ahead to Q1 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Dyadic International, Inc.

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.04

Actual

-$0.06

Surprise

-30.72%

TELA Bio, Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.18

Actual

-$0.16

Surprise

+14.12%

BioCardia, Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.17

Actual

-$0.06

Surprise

+65.40%

Celcuity Inc. Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$1.06

Actual

-$0.97

Surprise

+8.72%

Precigen, Inc. Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.08

Actual

-$0.01

Surprise

+88.24%

Absci Corporation Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.19

Actual

-$0.23

Surprise

-16.04%

Candel Therapeutics, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.25

Actual

-$0.54

Surprise

-115.31%

LENZ Therapeutics, Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.99

Actual

-$1.15

Surprise

-17.10%

Fennec Pharmaceuticals Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

$0.03

Actual

-$0.11

Surprise

-408.12%

Equillium, Inc. Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.06

Actual

-$0.04

Surprise

+35.28%

FAQ

What were Creative Medical Technology Holdings, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, Creative Medical Technology Holdings, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of $3.00K, 0% as expectations.

How did the market react to Creative Medical Technology Holdings, Inc. Common Stock's Q4 2025 earnings?

The stock price moved down -3.09%, changed from $1.94 before the earnings release to $1.88 the day after.

When is Creative Medical Technology Holdings, Inc. Common Stock expected to report next?

The next earning report is scheduled for May 07, 2026.

What are the forecasts for Creative Medical Technology Holdings, Inc. Common Stock's next earnings report?

Based on -- analysts, Creative Medical Technology Holdings, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q1 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.